• 12479 Citations
  • 39 h-Index
1973 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
Article

Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer

Rubovszky, G., Budai, B., Ganofszky, E., Horváth, Z., Juhos, É., Madaras, B., Nagy, T., Szabó, E., Pintér, T., Tóth, E., Nagy, P., Láng, I. & Hitre, E., Apr 1 2018, In : Pathology and Oncology Research. 24, 2, p. 237-244 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab

Duchnowska, R., Sperinde, J., Czartoryska-Arlukowicz, B., Myśliwiec, P., Winslow, J., Radecka, B., Petropoulos, C., Demlova, R., Orlikowska, M., Kowalczyk, A., Láng, I., Ziółkowska, B., Debska-Szmich, S., Merdalska, M., Grela-Wojewoda, A., Zawrocki, A., Biernat, W., Huang, W. & Jassem, J., Jan 1 2017, In : Oncotarget. 8, 61, p. 104149-104159 11 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Mauriac, L., Keshaviah, A., Debled, M., Mouridsen, H., Forbes, J. F., Thürlimann, B., Paridaens, R., Monnier, A., Láng, I., Wardley, A., Nogaret, J. M., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., Coates, A. S., Smith, I., Viale, G., Rabaglio, M., Zabaznyi, N. & Goldhirsch, A., May 2007, In : Annals of Oncology. 18, 5, p. 859-867 9 p.

Research output: Contribution to journalArticle

112 Citations (Scopus)

Preoperative work up and therapeutic schedule for patients with duplex tumors.

Jobaházi, J., Láng, I., Szentpétery, F. & Jakab, F., 1997, In : Acta Chirurgica Hungarica. 36, 1-4, p. 147-149 3 p.

Research output: Contribution to journalArticle

Preoperatív kemoterápia a colorectalis májáttétes betegek sebészi kezelésében

Translated title of the contribution: Preoperative chemotherapy in the surgical treatment of colorectal liver metastasesDede, K., Láng, I., Pörneczi, B., Mester, G., Fekete, A., Kőszegi, G., Mersich, T., Besznyák, I. & Bursics, A., Dec 1 2013, In : Magyar sebészet. 66, 6, p. 325-330 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer

Wapnir, I. L., Aebi, S., Gelber, S., Anderson, S. J., Láng, I., Robidoux, A., Mamounas, E. P. & Wolmark, N., Nov 1 2008, In : Annals of Surgical Oncology. 15, 11, p. 3227-3231 5 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

Láng, I., Köhne, C. H., Folprecht, G., Rougier, P., Curran, D., Hitre, E., Sartorius, U., Griebsch, I. & Van Cutsem, E., Jan 1 2013, In : European Journal of Cancer. 49, 2, p. 439-448 10 p.

Research output: Contribution to journalArticle

41 Citations (Scopus)

Radio-guided resection of non-palpable rectal carcinoma following polypectomy

Mersich, T., Lang, I., Balogh, I. & Jakob, F., Apr 1 2007, In : Hepato-Gastroenterology. 54, 75, p. 751-752 2 p.

Research output: Contribution to journalArticle

Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: Comparison of the effects of immunopotentiators of biological and synthetic origin in vitro

Nékám, K., Hugh Fudenberg, H., Mándi, B., Láng, I., Gergely, P. & Petrányi, G., Feb 1981, In : Immunopharmacology. 3, 1, p. 31-39 9 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Retroperitoneális plazmasejtes óriás nyirokcsomó hiperplázia.

Translated title of the contribution: Giant retroperitoneal plasma cell lymph node hyperplasiaLáng, I., Kopper, L., Magyarosy, E. & Petrányi, G., May 10 1981, In : Orvosi hetilap. 122, 19, p. 1139-1141 3 p.

Research output: Contribution to journalArticle

Retroperitoneal plasmocytic giant lymph node hyperplasia

Lang, I., Kopper, L., Magyarosy, E., Lapis, K. & Petrányi, G., Dec 1 1984, In : Journal of the Royal Society of Medicine. 77, 6, p. 517-519 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Jerusalem, G., Mariani, G., Ciruelos, E. M., Martin, M., Tjan-Heijnen, V. C. G., Neven, P., Gavila, J. G., Michelotti, A., Montemurro, F., Generali, D., Simoncini, E., Lang, I., Mardiak, J., Naume, B., Camozzi, M., Lorizzo, K., Bianchetti, S. & Conte, P., Sep 1 2016, In : Annals of Oncology. 27, 9, p. 1719-1725 7 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

Lang, I., Inbar, M. J., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G. G., Messinger, D., Brodowicz, T. & Zielinski, C., Nov 1 2012, In : European Journal of Cancer. 48, 17, p. 3140-3149 10 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz, T., Lang, I., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Petruzelka, L., Eniu, A., Anghel, R., Koynov, K., Vrbanec, D., Pienkowski, T., Melichar, B., Spanik, S., Ahlers, S., Messinger, D., Inbar, M. J. & Zielinski, C., Nov 25 2014, In : British journal of cancer. 111, 11, p. 2051-2057 7 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Significance of histomorphology of early triple-negative breast cancer

Rubovszky, G., Horváth, Z., Tóth, E., Láng, I. & Kásler, M., Oct 1 2012, In : Pathology and Oncology Research. 18, 4, p. 823-831 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Silymarin (Legalon) kezelés hatása idült alkoholos májbetegek antioxidáns védörendszerére és a lipid peroxidációra (kettös vak protokoll).

Translated title of the contribution: Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)Müzes, G., Deák, G., Láng, I., Nékám, K., Niederland, V. & Fehér, J., Apr 22 1990, In : Orvosi hetilap. 131, 16, p. 863-866 4 p.

Research output: Contribution to journalArticle

34 Citations (Scopus)

Simultaneous insulin immunoassay in sera, heparin and EDTA plasma

Balaszi, I., Stutzel, M., Littmann, L. & Lang, I., Dec 1 1974, In : REV.ROUM.MED.. 12, 3, p. 175-180 6 p.

Research output: Contribution to journalArticle

SLE-s és metasztatizáló szolid tumoros betegek természetes és lektin-dependens sejtes citotoxicitásának vizsgálata.

Translated title of the contribution: Natural and lectin-dependent cell-mediated cytotoxicity in patients with SLE and metastasizing solid tumorsPerl, A., Rhenso, G. C., Láng, I., Nékám, K. & Gergely, P., Jan 15 1984, In : Orvosi hetilap. 125, 3, p. 135-137 3 p.

Research output: Contribution to journalArticle

Studies on the monocyte interleukin-1 and tumour necrosis factor-alpha production in patients with alcoholic liver cirrhosis.

Müzes, G., Deák, G., Láng, I., González-Cabello, R., Gergely, P. & Fehér, J., 1989, In : Acta medica Hungarica. 46, 4, p. 253-261 9 p.

Research output: Contribution to journalArticle

Successful treatment of solitary bone metastasis of non-small cell lung cancer with bevacizumab and hyperthermia

Rubovszky, G., Nagy, T., Gődény, M., Szász, A. & Láng, I., Jan 2013, In : Pathology and Oncology Research. 19, 1, p. 119-122 4 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Lang, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral Pena, J. C., Adamchuk, H., Hickish, T. & 5 others, de la Pena, L., Jackisch, C., Gelber, R. D., Piccart-Gebhart, M. & Di Cosimo, S., Sep 2019, In : European Journal of Cancer. 118, p. 169-177 9 p.

Research output: Contribution to journalArticle

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Huober, J., Cole, B. F., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J. F., Neven, P., Láng, I., Smith, I., Wardley, A., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Gelber, R. D. & Thürlimann, B., Jan 2014, In : Breast Cancer Research and Treatment. 143, 1, p. 159-169 11 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Systemás lupus erythematosusban szenvedö betegek antitesttöl függö, sejthez kötött cytotocicitásáról.

Translated title of the contribution: Antibody dependent cell-bound cytotoxicity in systemic lupus erythematosusLáng, I., Fekete, B., Török, K., Pálóczi, K., Sonkoly, I., Szegedi, G. & Gergely, P., Jul 30 1978, In : Orvosi hetilap. 119, 31, p. 1885-1887 3 p.

Research output: Contribution to journalArticle

The ADCC activity of malignant tumor patients

Lang, I., Fekete, B. & Petranyi, J., Jan 1 1978, In : Magyar onkologia. 22, 3, p. 189-194 6 p.

Research output: Contribution to journalArticle

The ADCC activity of malignant tumor patients following radiotherapy

Lang, I., Petranyi, J. & Fekete, B., Jan 1 1978, In : Magyar onkologia. 22, 3, p. 184-188 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

Afzal, S., Gusella, M., Jensen, S. A., Vainer, B., Vogel, U., Andersen, J. T., Brødbæk, K., Petersen, M., Jimenez-Solem, E., Adleff, V., Budai, B., Hitre, E., Lng, I., Orosz, E., Bertolaso, L., Barile, C., Padrini, R., Kralovnszky, J., Pasini, F. & Poulsen, H. E., Sep 1 2011, In : Pharmacogenomics. 12, 9, p. 1257-1267 11 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): A randomised phase 2 study

Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., Shparyk, Y., Thummala, A. R., Voytko, N. L., Fowst, C., Huang, X., Kim, S. T., Randolph, S. & Slamon, D. J., Jan 1 2015, In : The Lancet Oncology. 16, 1, p. 25-35 11 p.

Research output: Contribution to journalArticle

897 Citations (Scopus)

The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response

Elek, G., Láng, I., Szende, B. & Lapis, K., Apr 1982, In : Agents and Actions. 12, 4, p. 503-507 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

The effect of transfer factor on spontaneous shedding of sheep red blood cell binding receptors of T lymphocytes in vitro

Nekam, K., Varro, R., Torok, K., Láng, I., Kalmár, L., Gergely, P. & Petrányi, G., Dec 1 1980, In : Acta medica Academiae Scientiarum Hungaricae. 37, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

The effect of transfer factor therapy on antibody dependent cellular cytotoxicity

Lang, I., Nekam, K., Torok, K. & Gergely, P., Jan 1 1979, In : Orvosi hetilap. 120, 25, p. 1491-1495 5 p.

Research output: Contribution to journalArticle

The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma

Pápai, Z., Bodoky, G., Szánté, J., Poller, I., Rahóty, P., Eckhardt, S., Láng, I. & Szendröi, M., Jul 1 2000, In : Cancer. 89, 1, p. 177-180 4 p.

Research output: Contribution to journalArticle

25 Citations (Scopus)

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Van Cutsem, E., Dicato, M., Arber, N., Benson, A., Cunningham, D., Diaz-Rubio, E., Glimelius, B., Goldberg, R., Haller, D., Haustermans, K., Koo-Kang, Y., Labianca, R., Lang, I., Minsky, B., Nordlinger, B., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J. & 2 others, Szawlowski, A. & van de Velde, C., Jun 1 2006, In : Annals of Oncology. 17, SUPPL. 6, p. vi13-vi18

Research output: Contribution to journalArticle

26 Citations (Scopus)
9 Citations (Scopus)

Therapeutic results: report of the Hungarian children's leukaemia study group

Schuler, D., Galfi, I., Istvan, L., Kassai, P., Kemény, P., Laub, M. W., Romhányi, J., Székely, K., Velkey, L., Virág, I. & Zimonyi, I., Dec 1 1976, In : Haematologia. 10, 1, p. 51-56 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The superoxide scavenging activity of dihydroquinoline type derivatives (CH402 and MTDQ-DA)

Prònai, L., Blåzovics, A., Horvåth, M., Lång, I. & Fehér, J., Jan 1 1993, In : Free radical research. 19, 5, p. 287-296 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
6 Citations (Scopus)

Transfer factorral kezelt krónikus candidiasis esete

Translated title of the contribution: A case of chronic candidiasis treated with transfer factorNékám, K., Gürtler, A., Kalmár, L., Láng, I. & Petrányi, G., Dec 1 1975, In : Fogorvosi szemle. 68, 12, p. 369-372 4 p.

Research output: Contribution to journalArticle

Trastuzumab (Herceptin) a HER-2-pozitív korai emlorák adjuváns kezelésében

Translated title of the contribution: Trastuzumab (Herceptin) in the adjuvant teatment of HER-2-positive early breast cancerLáng, I. & Hitre, E., Dec 1 2006, In : Magyar onkologia. 50, 4, p. 293-302 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., Cameron, D., Dowsett, M., Barrios, C. H., Steger, G., Huang, C. S., Andersson, M., Inbar, M., Lichinitser, M., Láng, I., Nitz, U. & 12 others, Iwata, H., Thomssen, C., Lohrisch, C., Suter, T. M., Rüschoff, J., Süto, T., Greatorex, V., Ward, C., Straehle, C., McFadden, E., Dolci, M. S. & Gelber, R. D., Oct 20 2005, In : New England Journal of Medicine. 353, 16, p. 1659-1672 14 p.

Research output: Contribution to journalArticle

3657 Citations (Scopus)

Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: Final results of the retreatment after herceptin adjuvant trial

Láng, I., Bell, R., Feng, F. Y., Lopez, R. I., Jassem, J., Semiglazov, V., Al-Sakaff, N., Heinzmann, D. & Chang, J., Feb 1 2014, In : Clinical Oncology. 26, 2, p. 81-89 9 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)

Treatment adherence and its impact on Disease-Free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Láng, I., Colleoni, M. & Thürlimann, B., Jul 20 2016, In : Journal of Clinical Oncology. 34, 21, p. 2452-2459 8 p.

Research output: Contribution to journalArticle

68 Citations (Scopus)
6 Citations (Scopus)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Pruneri, G., Gray, K. P., Vingiani, A., Viale, G., Curigliano, G., Criscitiello, C., Láng, I., Ruhstaller, T., Gianni, L., Goldhirsch, A., Kammler, R., Price, K. N., Cancello, G., Munzone, E., Gelber, R. D., Regan, M. M. & Colleoni, M., Jul 1 2016, In : Breast Cancer Research and Treatment. 158, 2, p. 323-331 9 p.

Research output: Contribution to journalArticle

49 Citations (Scopus)

Tumoros betegek csökkent természetes limfocitotoxicitásának fokozása transzfer faktor kezeléssel.

Translated title of the contribution: Enhancing decreased natural lymphocytotoxicity in tumor patients by transfer factor therapyLáng, I., Nékám, K., Gergely, P. & Petrányi, G., Apr 3 1983, In : Orvosi hetilap. 124, 14, p. 807-810 4 p.

Research output: Contribution to journalArticle

Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

Bellet, M., Gray, K. P., Francis, P. A., Láng, I., Ciruelos, E., Lluch, A., Climent, M. A., Catalán, G., Avella, A., Bohn, U., González-Martin, A., Ferrer, R., Catalán, R., Azaro, A., Rajasekaran, A., Morales, J., Vázquez, J., Fleming, G. F., Price, K. N. & Regan, M. M., May 10 2016, In : Journal of Clinical Oncology. 34, 14, p. 1584-1593 10 p.

Research output: Contribution to journalArticle

48 Citations (Scopus)

Újabb klinikai adatok a daganatos betegek anémiá jának erythropoetinkezelésében

István, L., Jan 1 2005, In : Magyar onkologia. 49, 3, p. 251-254 4 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Ujabb klinikai adatok a daganatos betegek anémiájának erythropoetinkezelésében. Az Amerikai Klinikai Onkológiai Társaság (ASCO) 2005. évi orlandói kongresszusán bemutatott fontosabb eredmények összefoglalása.

Translated title of the contribution: New clinical data on erythropoietin therapy of cancer patients with anemia. Summary of the major presentations at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, 2005Láng, I., 2005, In : Magyar Onkologia. 49, 3, p. 251-254 4 p.

Research output: Contribution to journalArticle